Michael Aksenov - Publications

Affiliations: 
University of South Carolina, Columbia, SC 

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Adams SM, Aksenova MV, Aksenov MY, Mactutus CF, Booze RM. Soy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat(1-86) exposure. Plos One. 7: e37540. PMID 22629415 DOI: 10.1371/Journal.Pone.0037540  0.653
2012 Moran LM, Aksenov MY, Booze RM, Webb KM, Mactutus CF. Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge. Current Hiv Research. 10: 415-24. PMID 22591365 DOI: 10.2174/157016212802138788  0.614
2012 Aksenov MY, Aksenova MV, Mactutus CF, Booze RM. D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 599-608. PMID 22552781 DOI: 10.1007/s11481-012-9362-3  0.635
2011 Bertrand SJ, Aksenova MV, Aksenov MY, Mactutus CF, Booze RM. Endogenous amyloidogenesis in long-term rat hippocampal cell cultures. Bmc Neuroscience. 12: 38. PMID 21569253 DOI: 10.1186/1471-2202-12-38  0.552
2010 Aksenov MY, Aksenova MV, Mactutus CF, Booze RM. HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures. Neuroscience Letters. 475: 174-8. PMID 20363291 DOI: 10.1016/J.Neulet.2010.03.073  0.65
2010 Adams SM, Aksenova MV, Aksenov MY, Mactutus CF, Booze RM. ER-β mediates 17β-estradiol attenuation of HIV-1 Tat-induced apoptotic signaling. Synapse (New York, N.Y.). 64: 829-38. PMID 20340172 DOI: 10.1002/Syn.20793  0.551
2010 Webb KM, Aksenov MY, Mactutus CF, Booze RM. Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat. Journal of Neurovirology. 16: 168-73. PMID 20337512 DOI: 10.3109/13550281003690177  0.633
2009 Aksenov MY, Aksenova MV, Mactutus CF, Booze RM. Attenuated neurotoxicity of the transactivation-defective HIV-1 Tat protein in hippocampal cell cultures. Experimental Neurology. 219: 586-90. PMID 19615365 DOI: 10.1016/J.Expneurol.2009.07.005  0.624
2009 Aksenova MV, Aksenov MY, Adams SM, Mactutus CF, Booze RM. Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons. Experimental Neurology. 215: 253-63. PMID 19013459 DOI: 10.1016/J.Expneurol.2008.10.006  0.599
2008 Aksenov MY, Aksenova MV, Silvers JM, Mactutus CF, Booze RM. Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons. Neurotoxicology. 29: 971-7. PMID 18606182 DOI: 10.1016/J.Neuro.2008.06.003  0.618
2007 Silvers JM, Aksenova MV, Aksenov MY, Mactutus CF, Booze RM. Neurotoxicity of HIV-1 Tat protein: involvement of D1 dopamine receptor. Neurotoxicology. 28: 1184-90. PMID 17764744 DOI: 10.1016/J.Neuro.2007.07.005  0.662
2006 Silvers JM, Aksenov MY, Aksenova MV, Beckley J, Olton P, Mactutus CF, Booze RM. Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains. Journal of Neurovirology. 12: 140-5. PMID 16798675 DOI: 10.1080/13550280600724319  0.634
2006 Aksenov MY, Aksenova MV, Nath A, Ray PD, Mactutus CF, Booze RM. Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology. 27: 217-28. PMID 16386305 DOI: 10.1016/J.Neuro.2005.10.003  0.675
2006 Aksenova MV, Silvers JM, Aksenov MY, Nath A, Ray PD, Mactutus CF, Booze RM. HIV-1 Tat neurotoxicity in primary cultures of rat midbrain fetal neurons: changes in dopamine transporter binding and immunoreactivity. Neuroscience Letters. 395: 235-9. PMID 16356633 DOI: 10.1016/J.Neulet.2005.10.095  0.65
2005 Aksenova MV, Aksenov MY, Mactutus CF, Booze RM. Cell culture models of oxidative stress and injury in the central nervous system. Current Neurovascular Research. 2: 73-89. PMID 16181101 DOI: 10.2174/1567202052773463  0.553
2003 Aksenov MY, Hasselrot U, Wu G, Nath A, Anderson C, Mactutus CF, Booze RM. Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. Brain Research. 987: 1-9. PMID 14499939 DOI: 10.1016/S0006-8993(03)03194-9  0.663
2002 Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. Journal of Neurochemistry. 82: 1524-32. PMID 12354300 DOI: 10.1046/J.1471-4159.2002.01103.X  0.606
2002 Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radical Biology & Medicine. 33: 562-71. PMID 12160938 DOI: 10.1016/S0891-5849(02)00914-0  0.607
2001 Aksenov MY, Hasselrot U, Bansal AK, Wu G, Nath A, Anderson C, Mactutus CF, Booze RM. Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum. Neuroscience Letters. 305: 5-8. PMID 11356294 DOI: 10.1016/S0304-3940(01)01786-4  0.665
2001 Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR. Protein oxidation in the brain in Alzheimer's disease. Neuroscience. 103: 373-83. PMID 11246152 DOI: 10.1016/S0306-4522(00)00580-7  0.314
1999 Butterfield DA, Howard B, Yatin S, Koppal T, Drake J, Hensley K, Aksenov M, Aksenova M, Subramaniam R, Varadarajan S, Harris-White ME, Pedigo NW, Carney JM. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease. Life Sciences. 65: 1883-92. PMID 10576432 DOI: 10.1016/S0024-3205(99)00442-7  0.362
1999 Aksenova MV, Aksenov MY, Markesbery WR, Butterfield DA. Aging in a dish: age-dependent changes of neuronal survival, protein oxidation, and creatine kinase BB expression in long-term hippocampal cell culture. Journal of Neuroscience Research. 58: 308-17. PMID 10502287 DOI: 10.1002/(Sici)1097-4547(19991015)58:2<308::Aid-Jnr11>3.0.Co;2-#  0.329
1999 Yatin SM, Aksenov M, Butterfield DA. The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease. Neurochemical Research. 24: 427-35. PMID 10215518 DOI: 10.1023/A:1020997903147  0.377
1998 Yatin SM, Aksenova M, Aksenov M, Markesbery WR, Aulick T, Butterfield DA. Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses. Journal of Molecular Neuroscience : Mn. 11: 183-97. PMID 10344789 DOI: 10.1385/Jmn:11:3:183  0.406
1998 Butterfield DA, Koppal T, Howard B, Subramaniam R, Hall N, Hensley K, Yatin S, Allen K, Aksenov M, Aksenova M, Carney J. Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-tert-butyl-alpha-phenylnitrone and vitamin E. Annals of the New York Academy of Sciences. 854: 448-62. PMID 9928452 DOI: 10.1111/J.1749-6632.1998.Tb09924.X  0.391
1997 Butterfield DA, Hensley K, Cole P, Subramaniam R, Aksenov M, Aksenova M, Bummer PM, Haley BE, Carney JM. Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease. Journal of Neurochemistry. 68: 2451-7. PMID 9166739 DOI: 10.1046/J.1471-4159.1997.68062451.X  0.352
1995 Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita SP, Wu JF, Carney JM. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. Journal of Neurochemistry. 65: 2146-56. PMID 7595501 DOI: 10.1046/J.1471-4159.1995.65052146.X  0.377
Show low-probability matches.